<DOC>
	<DOC>NCT00534872</DOC>
	<brief_summary>The purpose of this study is to determine the blood levels and the tolerability of SB-649868 in Elderly and Female population</brief_summary>
	<brief_title>A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population</brief_title>
	<detailed_description />
	<criteria>INCLUSION CRITERIA: Healthy adult and elderly female and male Female must be of nonchildbearing potential Body weight =50 kg EXCLUSION CRITERIA: Abuse of alcohol or drugs Positive for Hepatitis B surface antigen, Hepatitis C antibody or HIV Use of prescription or nonprescription drugs within 7 days prior to the first dose of study medication Smoking history of = 10 cigarettes a day in the last three months History of cardiovascular,psychiatric,autoimmune, respiratory or relevant gastrointestinal diseases Participation in clinical trial during the previous 6 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>4 Parallel cohorts</keyword>
	<keyword>Healthy Female</keyword>
	<keyword>Healthy Elderly</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>Safety and Tolerability</keyword>
</DOC>